AstraZeneca launches its new diabetes drug Onglyza

The world's seventh-largest pharma company, AstraZeneca Pharma and biopharmaceutical firm Bristol-Myers Squibb have launched their 9-month-old diabetes drug Onglyza in India - the biggest market for the drug.

Related Videos